LIfT BioSciences Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Employees
  • 12
Employees
  • Latest Deal Type
  • Series A
  • (Upcoming)
  • Investors
  • 6

LIfT BioSciences General Information

Description

Operator of a biotech start-up intended to develop cell bank of cancer killing neutrophils. The company's services mainly focus on offering allogeneic innate cell therapy that is mass-produced from stem cells in a GMP closed bioreactor system that enables superior economies of scale than autologous therapies, enabling caregivers to destroy all solid tumours, irrespective of strain or mutation.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare
Primary Office
  • Stevenage Bioscience Catalyst, Gunnels Wood Road
  • Herts
  • Stevenage SG1 2FX
  • England, United Kingdom

LIfT BioSciences Timeline

2017201820192020
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

LIfT BioSciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC (Series A) 01-Dec-2020 Upcoming Generating Revenue
7. Seed Round 15-Jan-2020 00.000 00.000 Completed Generating Revenue
6. Early Stage VC 29-Aug-2019 00000 00.000 00.000 Completed Generating Revenue
5. Accelerator/Incubator 12-Feb-2019 00.000 Completed Generating Revenue
4. Seed Round 23-Mar-2018 00000 00.000 00.000 Completed Generating Revenue
3. Grant 24-Mar-2017 00000 Completed Generating Revenue
2. Accelerator/Incubator 06-Feb-2017 $185K Completed Generating Revenue
1. Corporate 31-Jan-2017 $185K $185K Completed Generating Revenue
To view LIfT BioSciences’s complete valuation and funding history, request access »

LIfT BioSciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary 0,000 00.000000 0000.00 0000.00 00 0000.00 00.000
Ordinary 0,000 00.000000 0000.00 0000.00 00 0000.00 00.000
To view LIfT BioSciences’s complete cap table history, request access »

LIfT BioSciences Executive Team (6)

Name Title Board Seat Contact Info
Alexander Blyth Co-Founder & Chief Executive Officer
Dee Athwal Chief Business & Strategy Officer
Zheng Cui Ph.D Chief Scientific Advisor
Panteli Theocharous Chief Medical Officer
Jonathan Milner Ph.D Funding & Growth Advisor
You’re viewing 5 of 6 executive team members. Get the full list »

LIfT BioSciences Board Members (1)

Name Representing Role Since
John Gonzalez-Carvajal LIfT BioSciences Chairman 000 0000
To view LIfT BioSciences’s complete board members history, request access »

LIfT BioSciences Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

LIfT BioSciences Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Downing Ventures Venture Capital Minority 000 0000 000000 0
Jonathan Milner Angel (individual) Minority 000 0000 000000 0
Kizoo Technology Capital Venture Capital Minority 000 0000 000000 0
European Institute of Innovation and Technology Corporation 000 0000 000000 0
MedCity Corporation 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »